Longboard Pharmaceuticals, Inc. Accrued Professional Fees, Current
Longboard Pharmaceuticals, Inc. had Accrued Professional Fees, Current of $685.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2024-11-07
- 2024-09-30: Accrued Professional Fees, Current $685.00K.
- 2024-06-30: Accrued Professional Fees, Current $224.00K.
- 2024-03-31: Accrued Professional Fees, Current $177.00K.
- 2023-12-31: Accrued Professional Fees, Current $218.00K.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2024-09-30 | $685.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $224.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $177.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $218.00K 10-Q · filed 2024-11-07 | |
| 2023-09-30 | $259.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $412.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $412.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $254.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | $143.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $278.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $154.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $97.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $99.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $65.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $152.00K 10-K · filed 2022-03-03 | $115.00K 10-Q · filed 2021-05-10 |